05116nam 2200625 450 991046397860332120200520144314.00-309-26596-7(CKB)2670000000499677(EBL)3379261(SSID)ssj0000957117(PQKBManifestationID)11509316(PQKBTitleCode)TC0000957117(PQKBWorkID)10964736(PQKB)10506100(MiAaPQ)EBC3379261(Au-PeEL)EBL3379261(CaPaEBR)ebr10863916(OCoLC)823904672(EXLCZ)99267000000049967720130814h20132013 uy| 0engurcnu||||||||txtccrDeveloping and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis workshop summary /Anna Nicholson [and three others], Rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National AcademiesWashington, District of Columbia :National Academies Press,[2013]©20131 online resource (171 p.)"Forum on drug discovery, development, and translation."--Cover."Workshop was held on July 31- August 1, 2012 in Washington, D.C.0-309-26595-9 Includes bibliographical references (pages 111-113).Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions.To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB) a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin) face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent of the estimated 5 million MDR TB cases globally were treated with drugs of known quality and in programs capable of delivering appropriate care (Keshavjee, 2012). The vast majority of MDR TB patients either died from lack of treatment or contributed to the spread of MDR TB in their communities. A strengthened global supply chain for SLDs could save lives by consistently delivering high quality medicines to more of the people who need them. This public workshop explored innovative solutions to the problem of how to get the right SLDs for MDR TB to people who critically need them. More specifically, the workshop examined current problems and potential opportunities for coordinated international efforts to ensure that a reliable and affordable supply of high-quality SLDs is available. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis: Workshop Summary covers the objectives of the workshop, which were to review: To what extent and in what ways current mechanisms are or are not effectively accomplishing what is needed, including consideration of bottlenecks ; The advantages and disadvantages of centralization in the management of the global drug supply chain, and potential decentralized approaches to improve operations of the supply chain ; What can be learned from case studies and examples from other diseases (e.g., the Affordable Medicines Facility-malaria (AMFm) and the U.S. President's Emergency Plan for AIDS Relief [PEPFAR]) ; The current allocation of responsibilities and roles of the private (including industry and nonprofit public health organizations) and public sectors, and examination of opportunities for enhancing and optimizing collaboration ; Identification of potential innovative solutions to the problem.Multidrug-resistant tuberculosisPreventionCongressesBusiness logisticsCongressesInternational cooperationCongressesElectronic books.Multidrug-resistant tuberculosisPreventionBusiness logisticsInternational cooperation362.19699/5Nicholson AnnaInstitute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation,Institute of Medicine (U.S.).Board on Health Sciences Policy,Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TBMiAaPQMiAaPQMiAaPQBOOK9910463978603321Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculosis1947786UNINA03602oam 2200709I 450 991081734520332120240425212555.01-283-86217-41-136-29609-30-203-11565-110.4324/9780203115657(CKB)2670000000312409(EBL)1092782(OCoLC)820787729(SSID)ssj0000786931(PQKBManifestationID)12353253(PQKBTitleCode)TC0000786931(PQKBWorkID)10804077(PQKB)10359791(MiAaPQ)EBC1092782(Au-PeEL)EBL1092782(CaPaEBR)ebr10632444(CaONFJC)MIL417467(OCoLC)823387058(OCoLC)900237808(FINmELB)ELB134612(EXLCZ)99267000000031240920180706d2013 uy 0engur|n|---|||||txtccrThe Asian cinema experience styles, spaces, theory /Stephen Teo1st ed.Abingdon, Oxon :Routledge,2013.1 online resource (289 p.)Media, culture and social change in Asia ;30Description based upon print version of record.0-415-81514-2 0-415-57146-4 Includes bibliographical references and index.Includes filmography.pt. I. Styles -- pt. II. Spaces -- pt. III. Theory."This book explores the range and dynamism of contemporary Asian cinemas, covering East Asia (China, Japan, South Korea, Hong Kong, Taiwan), Southeast Asia (Thailand, Singapore, Malaysia), South Asia (Bollywood), and West Asia (Iran), in order to discover what is common about them and to engender a theory or concept of "Asian Cinema". It goes beyond existing work which provides a field survey of Asian cinema, probing more deeply into the field of Asian Cinema, arguing that Asian Cinema constitutes a separate pedagogical subject, and putting forward an alternative cinematic paradigm. The book covers "styles", including the works of classical Asian Cinema masters, and specific genres such as horror films, and Bollywood and Anime, two very popular modes of Asian Cinema; "spaces", including artistic use of space and perspective in Chinese cinema, geographic and personal space in Iranian cinema, the private "erotic space" of films from South Korea and Thailand, and the persistence of the family unit in the urban spaces of Asian big cities in many Asian films; and "concepts" such as Pan-Asianism, Orientalism, Nationalism and Third Cinema. The rise of Asian nations on the world stage has been coupled with a growing interest, both inside and outside Asia, of Asian culture, of which film is increasingly an indispensable component--this book provides a rich, insightful overview of what exactly constitutes Asian Cinema. "Provided by publisher.Media, culture, and social change in Asia series ;30.Motion picturesAsiaPopular cultureAsiaCulture in motion picturesMotion picturesPopular cultureCulture in motion pictures.791.43095PER004000SOC008000SOC052000bisacshTeo Stephen.865995MiAaPQMiAaPQMiAaPQBOOK9910817345203321The Asian cinema experience3957883UNINA